Topics

FDA Expands Use of Toujeo to Childhood Diabetes

04:27 EST 3 Dec 2019 | Medscape

First approved for US adults in 2015, Toujeo (insulin glargine 300 units/mL injection) may now be used in children as young as 6 years with type 1 or type 2 diabetes.
Medscape Medical News

Original Article: FDA Expands Use of Toujeo to Childhood Diabetes

NEXT ARTICLE

More From BioPortfolio on "FDA Expands Use of Toujeo to Childhood Diabetes"

Quick Search

Relevant Topic

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...